mefenamic acid has been researched along with resveratrol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Choi, S; Connelly, S; Johnson, SM; Kelly, JW; Mortenson, DE; Powers, ET; Wilson, IA | 1 |
De Santi, C; Mosca, F; Pacifici, GM; Pietrabissa, A; Spisni, R | 1 |
3 other study(ies) available for mefenamic acid and resveratrol
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Topics: Amyloid Neuropathies, Familial; Computer Simulation; Drug Design; Humans; Molecular Docking Simulation; Prealbumin; Protein Multimerization; Protein Stability; Small Molecule Libraries | 2017 |
Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum.
Topics: Adult; Aged; Biological Availability; Duodenum; Humans; Kinetics; Liver; Mefenamic Acid; Middle Aged; Molecular Structure; Phosphoadenosine Phosphosulfate; Quercetin; Resveratrol; Rosales; Salicylic Acid; Stilbenes; Sulfates; Sulfotransferases; Wine | 2000 |